Cite

HARVARD Citation

    Long, G. et al. (n.d.). Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. European journal of cancer. pp. S128-S129. [Online]. 
  
Back to record